Supporting patients with heart failure with digital therapeutics—A pilot study in Germany

S. Reif; S. Schubert; J. Stiefel; F. Husri; T. Fischlein; M. Pauschinger; J. Klucken

doi:10.1177/20552076221143899

Supporting patients with heart failure with digital therapeutics—A pilot study in Germany

S. Reif^*, S. Schubert, J. Stiefel, F. Husri, T. Fischlein, M. Pauschinger, J. Klucken

^*Corresponding author for this work

Digital Medicine

Research output: Contribution to journal › Article › Research › peer-review

2 Citations (Scopus)

Abstract

Objective: Continuous monitoring and targeted behavioral interventions have been shown to improve health status and quality of life for heart failure patients. Digital therapeutics offer the possibility to make more frequent monitoring and targeted behavioral interventions available for more people. Methods: We conduct a pilot study with 71 patients who were given a smartphone app and wearables for a 3-month period. Clinical indicators as well as patient-reported outcomes were collected at entry and exit examinations. Results: The New York Heart Association class remained stable or improved. Most quantitative outcome measures improved (6-minute walk test distance + 21 m, Kansas City Cardiomyopathy Questionnaire summary score + 6.0 points, European Heard Failure Self-care Behavior Scale summary score + 6.6 points, correct answers in the Atlanta Heart Failure Knowledge Test + 2.1), although the changes were mainly not significantly different from zero. There was no change in EQ-5D weight and 9-item Shared Decision-Making Questionnaire summary score. Conclusions: This before–after comparison shows that an app-based intervention can work as a digital therapeutic for heart failure patients.

Original language	English
Article number	20552076221143899
Journal	Digital Health
Volume	8
DOIs	https://doi.org/10.1177/20552076221143899
Publication status	Published - Dec 2022

Keywords

apps
Cardiovascular disease
digital health
quantitative
wearables

Access to Document

10.1177/20552076221143899Licence: CC BY-NC

Cite this

@article{d3bf0dafb97e4562883985462582f66f,

title = "Supporting patients with heart failure with digital therapeutics—A pilot study in Germany",

abstract = "Objective: Continuous monitoring and targeted behavioral interventions have been shown to improve health status and quality of life for heart failure patients. Digital therapeutics offer the possibility to make more frequent monitoring and targeted behavioral interventions available for more people. Methods: We conduct a pilot study with 71 patients who were given a smartphone app and wearables for a 3-month period. Clinical indicators as well as patient-reported outcomes were collected at entry and exit examinations. Results: The New York Heart Association class remained stable or improved. Most quantitative outcome measures improved (6-minute walk test distance + 21 m, Kansas City Cardiomyopathy Questionnaire summary score + 6.0 points, European Heard Failure Self-care Behavior Scale summary score + 6.6 points, correct answers in the Atlanta Heart Failure Knowledge Test + 2.1), although the changes were mainly not significantly different from zero. There was no change in EQ-5D weight and 9-item Shared Decision-Making Questionnaire summary score. Conclusions: This before–after comparison shows that an app-based intervention can work as a digital therapeutic for heart failure patients.",

keywords = "apps, Cardiovascular disease, digital health, quantitative, wearables",

author = "S. Reif and S. Schubert and J. Stiefel and F. Husri and T. Fischlein and M. Pauschinger and J. Klucken",

note = "Funding Information: We would like to thank Georg Zweyer for implementing the e-CRF tool and Sophie Terheyden as well as Till Gladow for excellent project management and valuable comments. The publication of this article was funded by the Open Access Fund of the Leibniz Association. Funding Information: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was financed by ProCarement GmbH, the developers of the ProHerz App evaluated in this article. Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

doi = "10.1177/20552076221143899",

language = "English",

volume = "8",

journal = "Digital Health",

issn = "2055-2076",

publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Supporting patients with heart failure with digital therapeutics—A pilot study in Germany

AU - Reif, S.

AU - Schubert, S.

AU - Stiefel, J.

AU - Husri, F.

AU - Fischlein, T.

AU - Pauschinger, M.

AU - Klucken, J.

N1 - Funding Information: We would like to thank Georg Zweyer for implementing the e-CRF tool and Sophie Terheyden as well as Till Gladow for excellent project management and valuable comments. The publication of this article was funded by the Open Access Fund of the Leibniz Association. Funding Information: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was financed by ProCarement GmbH, the developers of the ProHerz App evaluated in this article. Publisher Copyright: © The Author(s) 2022.

PY - 2022/12

Y1 - 2022/12

N2 - Objective: Continuous monitoring and targeted behavioral interventions have been shown to improve health status and quality of life for heart failure patients. Digital therapeutics offer the possibility to make more frequent monitoring and targeted behavioral interventions available for more people. Methods: We conduct a pilot study with 71 patients who were given a smartphone app and wearables for a 3-month period. Clinical indicators as well as patient-reported outcomes were collected at entry and exit examinations. Results: The New York Heart Association class remained stable or improved. Most quantitative outcome measures improved (6-minute walk test distance + 21 m, Kansas City Cardiomyopathy Questionnaire summary score + 6.0 points, European Heard Failure Self-care Behavior Scale summary score + 6.6 points, correct answers in the Atlanta Heart Failure Knowledge Test + 2.1), although the changes were mainly not significantly different from zero. There was no change in EQ-5D weight and 9-item Shared Decision-Making Questionnaire summary score. Conclusions: This before–after comparison shows that an app-based intervention can work as a digital therapeutic for heart failure patients.

AB - Objective: Continuous monitoring and targeted behavioral interventions have been shown to improve health status and quality of life for heart failure patients. Digital therapeutics offer the possibility to make more frequent monitoring and targeted behavioral interventions available for more people. Methods: We conduct a pilot study with 71 patients who were given a smartphone app and wearables for a 3-month period. Clinical indicators as well as patient-reported outcomes were collected at entry and exit examinations. Results: The New York Heart Association class remained stable or improved. Most quantitative outcome measures improved (6-minute walk test distance + 21 m, Kansas City Cardiomyopathy Questionnaire summary score + 6.0 points, European Heard Failure Self-care Behavior Scale summary score + 6.6 points, correct answers in the Atlanta Heart Failure Knowledge Test + 2.1), although the changes were mainly not significantly different from zero. There was no change in EQ-5D weight and 9-item Shared Decision-Making Questionnaire summary score. Conclusions: This before–after comparison shows that an app-based intervention can work as a digital therapeutic for heart failure patients.

KW - apps

KW - Cardiovascular disease

KW - digital health

KW - quantitative

KW - wearables

UR - http://www.scopus.com/inward/record.url?scp=85145023722&partnerID=8YFLogxK

UR - https://pubmed.ncbi.nlm.nih.gov/36583086

U2 - 10.1177/20552076221143899

DO - 10.1177/20552076221143899

M3 - Article

C2 - 36583086

AN - SCOPUS:85145023722

SN - 2055-2076

VL - 8

JO - Digital Health

JF - Digital Health

M1 - 20552076221143899

ER -

Supporting patients with heart failure with digital therapeutics—A pilot study in Germany

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this